J C Lormeau - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

J C Lormeau

Showing results (51-60 of 56) with videos related to

Pageof 6

Sort By:

You have reached the last page of results.This site can display upto 56 results.

Circulation Research|September 1, 1996

Biochemical and pharmacological properties of SANORG 32701. Comparison with the "synthetic pentasaccharide' (SR 90107/ORG 31540) and standard heparinJ M Herbert, J P Hérault, A Bernat, et al.

Journal of Medicinal Chemistry|November 12, 1993

Preparation and anti-HIV activity of O-acylated heparin and dermatan sulfate derivatives with low anticoagulant effectT Bârzu, M Level, M Petitou, et al.

British Journal of Haematology|November 1, 1994

Fraxiparin, a low-molecular-weight heparin, stimulates megakaryocytopoiesis in vitro and in vivo in miceZ X Shen, N Basara, X D Xi, et al.

Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|March 1, 1997

Absence of cross-reactivity of SR90107A/ORG31540 pentasaccharide with antibodies to heparin-PF4 complexes developed in heparin-induced thrombocytopeniaJ Amiral, J C Lormeau, A Marfaing-Koka, et al.

Blood|May 30, 1998

Biochemical and pharmacological properties of SANORG 34006, a potent and long-acting synthetic pentasaccharideJ M Herbert, J P Hérault, A Bernat, et al.

Journal of Medicinal Chemistry|May 23, 1997

Synthesis and pharmacological properties of a close analogue of an antithrombotic pentasaccharide (SR 90107A/ORG 31540)M Petitou, P Duchaussoy, G Jaurand, et al.

Pageof 6

Search research articles

Showing results (51-60 of 56) with videos related to

Sort By:

Pageof 6

You have reached the last page of results.This site can display upto 56 results.

Circulation Research|September 1, 1996

Biochemical and pharmacological properties of SANORG 32701. Comparison with the "synthetic pentasaccharide' (SR 90107/ORG 31540) and standard heparinJ M Herbert, J P Hérault, A Bernat, et al.

Journal of Medicinal Chemistry|November 12, 1993

Preparation and anti-HIV activity of O-acylated heparin and dermatan sulfate derivatives with low anticoagulant effectT Bârzu, M Level, M Petitou, et al.

British Journal of Haematology|November 1, 1994

Fraxiparin, a low-molecular-weight heparin, stimulates megakaryocytopoiesis in vitro and in vivo in miceZ X Shen, N Basara, X D Xi, et al.

Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|March 1, 1997

Absence of cross-reactivity of SR90107A/ORG31540 pentasaccharide with antibodies to heparin-PF4 complexes developed in heparin-induced thrombocytopeniaJ Amiral, J C Lormeau, A Marfaing-Koka, et al.

Blood|May 30, 1998

Biochemical and pharmacological properties of SANORG 34006, a potent and long-acting synthetic pentasaccharideJ M Herbert, J P Hérault, A Bernat, et al.

Journal of Medicinal Chemistry|May 23, 1997

Synthesis and pharmacological properties of a close analogue of an antithrombotic pentasaccharide (SR 90107A/ORG 31540)M Petitou, P Duchaussoy, G Jaurand, et al.

Pageof 6